Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
Seminars in Thrombosis and Hemostasis
|
June 10, 2017
Clinical Scoring Systems in Thrombotic Microangiopathies
Pavan K Bendapudi, Vivek Upadhyay, Lova Sun, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2024
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
Lova Sun, Elizabeth A Handorf, Yunyun Zhou, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Brief Report: Not Created Equal: Survival Differences by <i>KRAS</i> Mutation Subtype in NSCLC Treated With Immunotherapy
Lova Sun, Yunyun Zhou, Elizabeth A Handorf, et al.
Journal of the Endocrine Society
|
September 19, 2024
Single-Institution Experience of Larotrectinib Therapy for Patients With <i>NTRK</i> Fusion-Positive Thyroid Carcinoma
Omar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
JAMA Oncology
|
April 15, 2021
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
Lova Sun, Miles Hsu, Roger B Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2025
"Off-Label" Use of Checkpoint Inhibitors in Patients With Negative or Unknown PD-L1 Status in Advanced Head and Neck Cancer
Margaret Stalker, Kewen Qu, Roger B Cohen, et al.
Circulation Research
|
May 13, 2021
Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection
Virginia S Hahn, Kathleen W Zhang, Lova Sun, et al.
Clinical Lung Cancer
|
November 30, 2024
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC
Margaret Stalker, Melina Marmarelis, Corey Langer, et al.
JAMA Network Open
|
August 19, 2024
Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC
Lova Sun, Roger B Cohen, Christopher A D'Avella, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
June 22, 2023
Risk of Cardiovascular Events Among Patients With Head and Neck Cancer
Lova Sun, Robert Brody, Danielle Candelieri, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
Seminars in Thrombosis and Hemostasis
|
June 10, 2017
Clinical Scoring Systems in Thrombotic Microangiopathies
Pavan K Bendapudi, Vivek Upadhyay, Lova Sun, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2024
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
Lova Sun, Elizabeth A Handorf, Yunyun Zhou, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Brief Report: Not Created Equal: Survival Differences by <i>KRAS</i> Mutation Subtype in NSCLC Treated With Immunotherapy
Lova Sun, Yunyun Zhou, Elizabeth A Handorf, et al.
Journal of the Endocrine Society
|
September 19, 2024
Single-Institution Experience of Larotrectinib Therapy for Patients With <i>NTRK</i> Fusion-Positive Thyroid Carcinoma
Omar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
JAMA Oncology
|
April 15, 2021
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
Lova Sun, Miles Hsu, Roger B Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2025
"Off-Label" Use of Checkpoint Inhibitors in Patients With Negative or Unknown PD-L1 Status in Advanced Head and Neck Cancer
Margaret Stalker, Kewen Qu, Roger B Cohen, et al.
Circulation Research
|
May 13, 2021
Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection
Virginia S Hahn, Kathleen W Zhang, Lova Sun, et al.
Clinical Lung Cancer
|
November 30, 2024
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC
Margaret Stalker, Melina Marmarelis, Corey Langer, et al.
JAMA Network Open
|
August 19, 2024
Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC
Lova Sun, Roger B Cohen, Christopher A D'Avella, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
June 22, 2023
Risk of Cardiovascular Events Among Patients With Head and Neck Cancer
Lova Sun, Robert Brody, Danielle Candelieri, et al.
Page
of 9